MSD Equilis® Prequenza is a vaccine for the active immunisation against equine influenza.
Equilis® Prequenza is indicated for the active immunisation of healthy horses and ponies against equine influenza to reduce severity and duration of clinical signs and to reduce the amount and duration of viral shedding after infection.
Basic vaccination course
All horses not previously vaccinated should receive 2 vaccinations of 1 dose with a 4-week interval. The basic vaccination course results in immunity to equine influenza lasting at least 5 months. Foals should be vaccinated from the age of 6 months. If vaccination is performed before 6 months of age full protection can be expected after the third vaccination (first revaccination).
The first revaccination (third dose) is given 5 months after the basic vaccination course. The revaccination with Equilis® Prequenza or Equilis® Prequenza TE results in immunity to equine influenza for at least 12 months.
The second revaccination is given 12 months after the first revaccination.
The alternate use, at 12-month intervals, of Equilis® Prequenza is recommended to maintain immunity levels for the influenza component.
Equilis Prequenza is a vaccine suspension containing per 1ml:
Purified saponin (adjuvant) : 375 µg
Reg. No. G3775 (Act 36/1947)
YOU MIGHT ALSO CONSIDER THESE PRODUCTS